In March 2025, the company declared new designs for a immediate-to-purchaser giving of its Wegovy weight loss drug. The company proven a different pharmacy, named NovoCare, which would cost buyers $499 per 30 days for access to the drug, lower than half the cost of the drug by way of other pharmaceutical distribution networks.[53]Noteworthy for its